Breaking News Instant updates and real-time market news.

AMRX

Amneal Pharmaceuticals

$3.45

-0.14 (-3.90%)

16:25
09/11/19
09/11
16:25
09/11/19
16:25

Amneal Pharmaceuticals assumed with a Sell at Guggenheim

Guggenheim analyst Dana Flanders assumed coverage of Amneal Pharmaceuticals with a Sell rating and a $2.50 price target. Flanders believes the current consensus is too optimistic about the company's forward growth prospects, and noted that his estimates are 10% below consensus.

  • 06

    Nov

AMRX Amneal Pharmaceuticals
$3.45

-0.14 (-3.90%)

07/30/19
HCWC
07/30/19
NO CHANGE
Target $28
HCWC
Neutral
Alkermes settlement close to best-case scenario, says H.C. Wainwright
H.C. Wainwright analyst Douglas Tsao says Alkermes' (ALKS) settlement and license agreement with Amneal Pharmaceuticals (AMRX) provides a "measure of needed visibility." There was some investor nervousness coming into the hearing and this settlement "represents close to a best-case scenario for Alkermes," Tsao tells investors in a research note. Vivitrol's growth has slowed but 12% volume growth in Q2 indicates the franchise can continue to be a contributor for the foreseeable future, adds the analyst. Tsao thinks the bull thesis for Alkermes hinges largely on the prospects for ALKS-4230. The update that patients on ALKS-4230 appear to avoid capillary leak syndrome, which has limited the utility of IL-2 therapies in the past, is important, according to Tsao. He keeps a Neutral rating on Alkermes with a $28 price target.
07/30/19
PIPR
07/30/19
NO CHANGE
PIPR
Neutral
Piper says Alkermes scores 'back-to-back wins' with settlement, Biogen data
Piper Jaffray analyst Danielle Brill said Alkermes (ALKS) has scored "back-to-back wins" with its announcement yesterday that it settled the ongoing Vivitrol patent dispute with Amneal (AMRX) and the news this morning that BIIB098 showed a statistically significant improvement on GI tolerability versus Tecfidera in a head-to-head Phase 3 trial. She still questions how meaningful the improvement in GI tolerability actually is, but thinks the drug may become a priority for partner Biogen (BIIB), Brill tells investors. The analyst, who views the news of the last two days as net positive for Alkermes, maintains her concerns about long-term value creation and the company's "dry pipeline," she said. Brill keeps a Neutral rating on Alkermes shares.
08/06/19
RHCO
08/06/19
NO CHANGE
Target $5
RHCO
Buy
Amneal Pharmaceuticals price target lowered to $5 from $9 at SunTrust
SunTrust analyst Gregg Gilbert lowered his price target on Amneal Pharmaceuticals to $5 after its Q2 earnings miss and announced departures of "industry veterans" Chairman and CEO, saying his updated model now anticipates lower revenue and gross margins for the company's generics business. The analyst also maintains a Buy rating on Amneal Pharmaceuticals but recommends that investors take a wait-and-see approach before considering a long position.
09/11/19
GUGG
09/11/19
INITIATION
Target $2.5
GUGG
Sell
Amneal Pharmaceuticals initiated with a Sell at Guggenheim
Guggenheim analyst Dana Flanders started Amneal Pharmaceuticals with a Sell rating and $2.50 price target.

TODAY'S FREE FLY STORIES

HAS

Hasbro

$100.00

-20.11 (-16.74%)

18:23
10/22/19
10/22
18:23
10/22/19
18:23
Hot Stocks
Hasbro CEO: We believe we can grow in Q4 »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 22

    Oct

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

SPY

SPDR S&P 500 ETF Trust

$299.01

-1.04 (-0.35%)

, SPX

S&P 500

$0.00

(0.00%)

18:22
10/22/19
10/22
18:22
10/22/19
18:22
General news
Trump tweets 'good news happening' on Turkey, Syria, Middle East »

President Donald Trump…

SPY

SPDR S&P 500 ETF Trust

$299.01

-1.04 (-0.35%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$69.11

0.37 (0.54%)

18:20
10/22/19
10/22
18:20
10/22/19
18:20
Periodicals
NY AG's office says Exxon should pay up to $1.6B in climate trial, NYP says »

Kevin Wallace, a lawyer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

XOM

Exxon Mobil

$69.11

0.37 (0.54%)

17:58
10/22/19
10/22
17:58
10/22/19
17:58
Periodicals
Exxon lawyer slams NY climate suit as trial opens, Bloomberg says »

Exxon Mobil attorney…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

TER

Teradyne

$59.24

-0.83 (-1.38%)

17:57
10/22/19
10/22
17:57
10/22/19
17:57
Hot Stocks
Teradyne jumps 6% after quarterly results, guidance based on 5G demand »

Shares of semiconductor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 31

    Oct

TER

Teradyne

$59.24

-0.83 (-1.38%)

17:53
10/22/19
10/22
17:53
10/22/19
17:53
Earnings
Teradyne sees Q4 EPS 73c-84c, consensus 61c »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 31

    Oct

LEVI

Levi Strauss

$17.59

0.58 (3.41%)

17:52
10/22/19
10/22
17:52
10/22/19
17:52
Hot Stocks
Levi Strauss EVP Love sells 204K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BK

BNY Mellon

$46.15

0.48 (1.05%)

, WFC

Wells Fargo

$50.63

0.18 (0.36%)

17:51
10/22/19
10/22
17:51
10/22/19
17:51
Periodicals
BNY Mellon vice chairman leaves lender, WSJ says »

Bill Daley, former White…

BK

BNY Mellon

$46.15

0.48 (1.05%)

WFC

Wells Fargo

$50.63

0.18 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 29

    Oct

  • 12

    Nov

  • 14

    Jan

FMBI

First Midwest

$20.13

0.11 (0.55%)

17:42
10/22/19
10/22
17:42
10/22/19
17:42
Earnings
First Midwest reports Q3 adjusted EPS 52c, consensus 49c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 13

    Nov

GVA

Granite Construction

$36.76

0.44 (1.21%)

17:33
10/22/19
10/22
17:33
10/22/19
17:33
Hot Stocks
Granite Construction awarded $15M airfield contract in North Carolina »

Granite announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

REZI

Resideo

$15.17

0.03 (0.20%)

, STZ

Constellation Brands

$196.67

2.055 (1.06%)

17:32
10/22/19
10/22
17:32
10/22/19
17:32
Hot Stocks
Resideo CFO Joseph Ragan to leave company to pursue other opportunities »

Resideo Technologies…

REZI

Resideo

$15.17

0.03 (0.20%)

STZ

Constellation Brands

$196.67

2.055 (1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$14.00

-0.58 (-3.98%)

17:31
10/22/19
10/22
17:31
10/22/19
17:31
Hot Stocks
Snap says average revenue per user was $2.12 in Q3, an increase of 33% y-o-y »

Says maps and gaming are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 21

    Nov

KFS

Kingsway Financial

$2.23

-0.045 (-1.98%)

17:28
10/22/19
10/22
17:28
10/22/19
17:28
Hot Stocks
NYSE extends Kingsway Financial deadline to be current with all SEC filings »

Kingsway Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REZI

Resideo

$15.17

0.03 (0.20%)

17:28
10/22/19
10/22
17:28
10/22/19
17:28
Hot Stocks
Resideo begins comprehensive operational and financial review »

Resideo has begun a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REZI

Resideo

$15.17

0.03 (0.20%)

17:27
10/22/19
10/22
17:27
10/22/19
17:27
Earnings
Resideo cuts FY19 revenue growth view to 2%-4% from 2%-5%, consensus $5.02B »

The company's new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REZI

Resideo

$15.17

0.03 (0.20%)

17:26
10/22/19
10/22
17:26
10/22/19
17:26
Earnings
Resideo reports preliminary Q3 revenue $1.226B, consensus $1.25B »

Reports preliminary Q3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HNGR

Hanger

$20.50

0.39 (1.94%)

, RTEC

Rudolph Technologies

$27.36

-0.12 (-0.44%)

17:21
10/22/19
10/22
17:21
10/22/19
17:21
Hot Stocks
Hanger to replace Rudolph Technologies in S&P 600 at open on 10/28 »

Nanometrics (NANO) is…

HNGR

Hanger

$20.50

0.39 (1.94%)

RTEC

Rudolph Technologies

$27.36

-0.12 (-0.44%)

NANO

Nanometrics

$34.01

0.03 (0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 07

    Nov

  • 08

    Nov

  • 13

    Nov

PSB

PS Business Parks

$184.20

-1.53 (-0.82%)

17:11
10/22/19
10/22
17:11
10/22/19
17:11
Earnings
PS Business Parks reports Q3 FFO $1.71, two estimates $1.73 »

Reports Q3 rental income…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 12

    Nov

EPSN

Epsilon Energy

$3.20

(0.00%)

17:06
10/22/19
10/22
17:06
10/22/19
17:06
Hot Stocks
Epsilon Energy CEO comments on recent well results »

Michael Raleigh, CEO,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CALX

Calix

$7.15

0.005 (0.07%)

17:06
10/22/19
10/22
17:06
10/22/19
17:06
Earnings
Calix sees Q4 non-GAAP EPS 6c-10c, consensus 11c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

NOW

ServiceNow

$228.26

-12.315 (-5.12%)

17:05
10/22/19
10/22
17:05
10/22/19
17:05
Hot Stocks
Breaking Hot Stocks news story on ServiceNow »

ServiceNow down 6.3% at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

  • 09

    Dec

  • 12

    Dec

CALX

Calix

$7.15

0.005 (0.07%)

17:05
10/22/19
10/22
17:05
10/22/19
17:05
Earnings
Calix reports Q3 non-GAAP EPS 6c, consensus 4c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

GSS

Golden Star Resources

$2.99

0.05 (1.70%)

17:04
10/22/19
10/22
17:04
10/22/19
17:04
Hot Stocks
Golden Star Resources to move corporate office, CFO Andre van Niekerk to leave »

Golden Star Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

TER

Teradyne

$59.24

-0.83 (-1.38%)

17:03
10/22/19
10/22
17:03
10/22/19
17:03
Earnings
Teradyne reports Q3 adjusted EPS 77c, consensus 70c »

Reports Q3 revenue $582M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 31

    Oct

UCBI

United Community Banks

$29.30

0.12 (0.41%)

17:02
10/22/19
10/22
17:02
10/22/19
17:02
Earnings
United Community Banks reports Q3 adjusted EPS 63c, consensus 58c »

On an operating basis,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.